Samargandi Osama A, Boudreau Colton, MacIssac Kaleigh, McGuire Connor, ElAbd Rawan, Helmi Adel, Tang David
Division of Plastic Surgery, Department of Surgery, King Abdulaziz University, Jeddah, Saudi Arabia.
Division of Plastic Surgery, Dalhousie University, Halifax, NS, Canada.
Plast Surg (Oakv). 2024 Nov;32(4):606-613. doi: 10.1177/22925503231172789. Epub 2023 May 26.
Excess opioid prescribing has societal impacts including addiction, dependence, and misuse. This study aims to investigate prescribing patterns and self-reported patient experiences with opioid use, pain control, and disposal of unused medication following common breast surgeries. A total of 46 patients undergoing 5 breast procedures were identified during a predefined 14-week period. All procedures were carried out at a single tertiary care hospital by 9 plastic surgeons. Provincial narcotic monitoring program provided linked prescription information for identified patients. All patients were invited to participate in a telephone interview regarding postoperative opioid use. A total of 41.6% of patients received and filled an opioid prescription following a breast procedure. Hydromorphone was the most commonly prescribed narcotic. The average number of opioid tablets dispensed following breast procedures was 31.9. Four percent of breast patients required an opioid refill. A total of 75% of breast patients used at least 1 over-the-counter analgesic, most commonly acetaminophen alone. Average self-reported pain score and total pain period were not significantly different between those using opioids and those not. A total of 6.7% and 23.1% of patients report returning excess narcotics to a pharmacy, while the majority report still having or self-disposing of excess tablets. Opioids are prescribed in excess for the breast procedures we analyzed. The majority of unused opioids were noted to still be at home or disposed of inappropriately. This suggests a role for reviewing opioid-prescribing patterns for common plastic surgery procedures to reduce the burden of the ongoing opioid epidemic.
阿片类药物过量处方具有社会影响,包括成瘾、依赖和滥用。本研究旨在调查常见乳腺手术后阿片类药物的处方模式以及患者自我报告的用药体验、疼痛控制情况和未使用药物的处置情况。在预定的14周期间内,共确定了46例接受5种乳腺手术的患者。所有手术均由9名整形外科医生在一家三级护理医院进行。省级麻醉药品监测项目提供了已确定患者的相关处方信息。所有患者均受邀参加关于术后阿片类药物使用情况的电话访谈。共有41.6%的患者在乳腺手术后接受并填写了阿片类药物处方。氢吗啡酮是最常开具的麻醉药品。乳腺手术后发放的阿片类药片平均数量为31.9片。4%的乳腺手术患者需要补充阿片类药物。共有75%的乳腺手术患者使用了至少一种非处方镇痛药,最常见的是单独使用对乙酰氨基酚。使用阿片类药物的患者和未使用阿片类药物的患者自我报告的平均疼痛评分和总疼痛期无显著差异。共有6.7%和23.1%的患者报告将多余的麻醉药品返还给了药房,而大多数患者报告仍持有或自行处置了多余的药片。对于我们分析的乳腺手术,阿片类药物存在过量处方的情况。大多数未使用的阿片类药物被发现仍在家中或被不当处置。这表明有必要审查常见整形手术的阿片类药物处方模式,以减轻持续的阿片类药物流行带来的负担。